Nucleotide Metabolism II - Kevin Ahern's BB 451 Lecture #40 2017

1,509 views · Published 11 February 2017 · 45:37 · Indexed 10 November 2026

Channel: Kevin Ahern's YouTube Videos - Lectures and More · 2017 · Education

Watch on YouTube

1. Contact - [email protected]
2. Kevin's lectures with The Great Courses - https://www.thegreatcoursesplus.com/biochemistry-and-molecular-biology-how-life-works?tn=Expert_tray_Course_1_0_12943 
3.  Kevin's Lecturio videos for medical students - https://www.lecturio.com/medical-courses/biochemistry.course
4. Course materials at https://kevingahern.com/biochemistry-resources/
5. Course video channel at https://www.youtube.com/watch?v=TXA6tsIv1Ac&list=PLlnFrNM93wqygqglti74WH8_mQxlgLPy5 
6.  Metabolic Melodies at https://teeheetime.com/category/lyrics-science/
7.  Kevin's Free Biochemistry books - https://kevingahern.com/biochemistry-resources/
8.  Kevin's Pre-med Audio course on Listenable - https://listenable.io/web/courses/143/kevin-aherns-guide-to-getting-into-medical-school/

1. AMP inhibits its own synthesis and GMP inhibits its own synthesis. AMP and GMP together inhibit PRPP amidotransferase and inhibit purine production completely, while only one only partly inhibits PRPP amidotransferase, thus allowing the other one to be made.

2. Nucleoside monophosphate kinases are specific for each nucleoside monophosphate. Thus, GMP kinase converts GMP to GDP and Adenylate kinase converts AMP to ADP. The reaction adenylate kinase catalyzes - AMP + ATP GOES TO ADP can also be reversed, thus allowing cells to make ATP from 2ADPs. The byproduct, AMP, is an indicator of low cellular energy.

3. Nucleoside diphosphokinase (NDPK) catalyzes conversion of all nucleoside diphosphosphate to nucleoside triphosphates. It primarily uses energy from ATP, but can use any triphosphate.

4. De novo synthesis of pyrimidines is fundamentally different from that of purines. In purine biosynthesis, the base is assembled on the sugar. In pyrimidine biosynthesis, the base is made apart from the sugar and later attached to it.

5. In de novo synthesis of nucleotides, ribonucleotides are synthesized first. Deoxyribonucleotides are made from ribonucleoside diphosphates. Atoms in the ring of pyrimidines come from aspartate and carbamoyl phosphate.

6. The enzyme carbamoyl phosphate synthetase (CPS II in the diagram) catalyzes the very first step in pyrimidine synthesis and is inhibited by UMP.

7. The most important regulatory enzyme for the entire pathway of pyrimidine biosynthesis is aspartate transcarbamoylase (ATCase), which plays an important role in balancing the amounts of purines and pyrimidines and also measuring the amount of energy available (via the amount of ATP present). The enzyme catalyzes the linkage of aspartate to carbamoyl phosphate and is allosterically activated by ATP and allosterically inactivated by CTP.

8. The first pyrimidine nucleotide made in the de novo pyrimidine pathway is UMP.

9. UMP is phosphorylated to UDP (by uridine monophosphate kinase) and then to UTP (by nucleoside diphosphokinase = NDPK) before conversion to CTP (catalyzed by CTP synthetase/synthase). Each nucleoside monophosphate has a specific kinase to convert it to the diphosphate, but all diphosphates (purines, pyrimidines, and all deoxyribonucleoside diphosphates) are converted to triphosphates by NDPK.

10. Conversion of UTP to CTP is catalyzed by the enzyme CTP synthase and it is inhibited by CTP, thus providing a balance between the amount of CTP and UTP.

11. CTP synthase balances cytidine and uridine nucleotides.

12. OMP decarboxylase catalyzes formation UMP by a decarboxylation reaction. This enzyme enhances the rate of the reaction by 10 to the 17th power

13. Catabolism of purine nucleotides proceeds through loss of phosphate (nucleotidases) and splitting of base from sugar (phosphorylases) to produce a base and ribose-1-phosphate.

14. Hypoxanthine is a direct product of breakdown of adenine and indirectly of the breakdown of guanine.

15. Breakdown of purine bases requires xanthine oxidase, which catalyzes formatioin of uric acid. Uric acid is involved in gout and it precipiates, forming crystals which can be painful to nerve cells.

16. Allopurinol inhibits xanthine oxidase and prevents uric acid formation. Uric acid is an important molecule for excretion of nitrogen compounds in some organisms, such as birds.

17. Salvage of hypoxanthine and guanine bases (forming GMP or IMP) requires the enzyme HGPRT, which is deficient in Lesch-Nyhan syndrome.

18. Pyrimidine catabolism involves cytidine and uridine nucleotides. They can be interconverted to other (deamination of cytidine yields uridine) and can be broken down to bases + sugars or assembled to make nucleosides/nucleotides from bases and sugars (and phosphates). Catabolism of the bases yields urea, ultimately.

19. Thus, catabolism of purines and pyrimidines is important in nitrogen metabolism.

20. Ribonucleotide reductase (RNR) catalyzes the formation of deoxyribonucleotides from ribonucleotides. The substrates are ribonucleoside diphosphates (ADP, GDP, CDP, or UDP) and the products are deoxyribonucleoside diphosphates (dADP, dGDP, dCDP, or dUDP).

More from this channel